Targeted Metabolomics Reveals Early Dominant Optic Atrophy Signature in Optic Nerves of Opa1delTTAG/+ Mice.
暂无分享,去创建一个
D. Milea | V. Desquiret-Dumas | D. Bonneau | P. Amati‐Bonneau | G. Lenaers | P. Reynier | V. Procaccio | S. Leruez | C. Verny | C. Hamel | M. Ferré | A. Chevrollier | G. Simard | S. Chupin | N. Gueguen | D. Prunier-Mirebeau | E. Sarzi | C. Gadras | L. Tessier | G. Rousseau | J. M. Chao De La Barca | Tanguy Chaumette | Emmanuelle Sarzi | Cédric Gadras
[1] M. Larsen,et al. Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy. , 2016, Human molecular genetics.
[2] J. Lyu,et al. Carnosine decreased neuronal cell death through targeting glutamate system and astrocyte mitochondrial bioenergetics in cultured neuron/astrocyte exposed to OGD/recovery , 2016, Brain Research Bulletin.
[3] D. Milea,et al. OPA1-related disorders: Diversity of clinical expression, modes of inheritance and pathophysiology , 2016, Neurobiology of Disease.
[4] P. Reynier,et al. Loss of functional OPA1 unbalances redox state: implications in dominant optic atrophy pathogenesis , 2016, Annals of clinical and translational neurology.
[5] Robert W. Taylor,et al. Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation , 2015, Journal of Medical Genetics.
[6] T. Harada,et al. Spermidine Ameliorates Neurodegeneration in a Mouse Model of Normal Tension Glaucoma. , 2015, Investigative ophthalmology & visual science.
[7] C. Nucci,et al. Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury , 2015, Molecular vision.
[8] M. Zeviani,et al. Syndromic parkinsonism and dementia associated with OPA 1 missense mutations , 2015, Annals of neurology.
[9] T. Harada,et al. Spermidine promotes retinal ganglion cell survival and optic nerve regeneration in adult mice following optic nerve injury , 2015, Cell Death and Disease.
[10] D. Milea,et al. Improved Locus‐Specific Database for OPA1 Mutations Allows Inclusion of Advanced Clinical Data , 2015, Human mutation.
[11] S. Züchner,et al. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier. , 2014, Brain : a journal of neurology.
[12] V. Desquiret-Dumas,et al. Early-onset Behr syndrome due to compound heterozygous mutations in OPA1. , 2014, Brain : a journal of neurology.
[13] M. Nebbioso,et al. Degenerative events in retina and optic nerve induced by inhibition of carnitine transport. , 2014, Journal of biological regulators and homeostatic agents.
[14] A. Garnier,et al. Altered skeletal muscle mitochondrial biogenesis but improved endurance capacity in trained OPA1‐deficient mice , 2013, The Journal of physiology.
[15] M. Larsen,et al. Sensorineural hearing loss in OPA1-linked disorders. , 2013, Brain : a journal of neurology.
[16] M. Miquel,et al. OPA1 loss of function affects in vitro neuronal maturation. , 2013, Brain : a journal of neurology.
[17] N. Boddaert,et al. The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse. , 2012, Brain : a journal of neurology.
[18] Mark Ellisman,et al. Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity , 2012, Cell Death and Differentiation.
[19] D. Bers,et al. OPA1 Mutation and Late-Onset Cardiomyopathy: Mitochondrial Dysfunction and mtDNA Instability , 2012, Journal of the American Heart Association.
[20] D. Milea,et al. Dominant optic atrophy , 2012, Orphanet Journal of Rare Diseases.
[21] G A Perkins,et al. A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics , 2011, Cell Death and Disease.
[22] R. Lewis,et al. Early-onset severe neuromuscular phenotype associated with compound heterozygosity for OPA1 mutations. , 2011, Molecular genetics and metabolism.
[23] Pete A. Williams,et al. Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy. , 2010, Brain : a journal of neurology.
[24] G. Risuleo,et al. Carnitine reduces the lipoperoxidative damage of the membrane and apoptosis after induction of cell stress in experimental glaucoma , 2010, Cell Death and Disease.
[25] Robert W. Taylor,et al. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. , 2010, Ophthalmology.
[26] C. Viero,et al. Characterization of Ca2+ Signalling in Postnatal Mouse Retinal Ganglion Cells: Involvement of OPA1 in Ca2+ Clearance , 2010, Ophthalmic genetics.
[27] D. Turnbull,et al. Multi-system neurological disease is common in patients with OPA1 mutations , 2010, Brain : a journal of neurology.
[28] D. Milea,et al. Genetically determined optic neuropathies. , 2010, Current opinion in neurology.
[29] P. Heiduschka,et al. Subtle neurological and metabolic abnormalities in an Opa1 mouse model of autosomal dominant optic atrophy , 2009, Experimental Neurology.
[30] G. Lenaers,et al. OPA1 functions in mitochondria and dysfunctions in optic nerve. , 2009, The international journal of biochemistry & cell biology.
[31] D. Wallace,et al. Heterozygous Mutation of Opa1 in Drosophila Shortens Lifespan Mediated through Increased Reactive Oxygen Species Production , 2009, PloS one.
[32] D. Milea,et al. Hereditary optic neuropathies share a common mitochondrial coupling defect , 2008, Annals of neurology.
[33] D. Bonneau,et al. MULTIPLE SCLEROSIS–LIKE DISORDER IN OPA1-RELATED AUTOSOMAL DOMINANT OPTIC ATROPHY , 2008, Neurology.
[34] C. Mannella,et al. The C. elegans Opa1 Homologue EAT-3 Is Essential for Resistance to Free Radicals , 2008, PLoS genetics.
[35] R. Schwarzenbacher,et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. , 2008, Brain : a journal of neurology.
[36] Robert W. Taylor,et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. , 2008, Brain : a journal of neurology.
[37] Jennifer R. Davies,et al. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. , 2007, Human molecular genetics.
[38] V. Mils,et al. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: Relevance to ADOA pathogenesis , 2007, Journal of cellular physiology.
[39] S. Beck,et al. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. , 2006, Brain : a journal of neurology.
[40] V. Mils,et al. Mitochondrial dynamics and disease, OPA1. , 2006, Biochimica et biophysica acta.
[41] P. Ruzza,et al. Carnosine and carnosine-related antioxidants: a review. , 2005, Current medicinal chemistry.
[42] G. Lenaers,et al. The human dynamin‐related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter‐membrane space , 2002, FEBS letters.
[43] S. Bhattacharya,et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28 , 2000, Nature Genetics.
[44] J. Grosgeorge,et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy , 2000, Nature Genetics.
[45] J. Sturman,et al. Axonal transport of putrescine, spermidine and spermine in normal and regenerating goldfish optic nerves , 1977, Brain Research.
[46] E. Bertini,et al. 'Behr syndrome' with OPA1 compound heterozygote mutations. , 2015, Brain : a journal of neurology.
[47] L. Pellegrini,et al. The dynamin GTPase OPA1: more than mitochondria? , 2013, Biochimica et biophysica acta.
[48] P. Chinnery,et al. OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. , 2011, Genome research.
[49] P. Chinnery,et al. LETTER TO THE EDITOR OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy , 2011 .